Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Riverside-San Bernardino-Ontario, CA MSA — October 2026
Riverside biotech pay splits: scientists up, regulatory and clinical down.
Research Scientist advertised pay hit a $150,000 metro median versus $130,339 nationally, while Clinical Research Associate pay fell to $75,000 locally even as the national figure climbed to $90,065.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Metro unemployment rate: 5.9% — Down from 6.2% in August; CA statewide at 5.1%
- Research Scientist advertised pay: $150,000 — vs $130,339 national median
- CRA advertised pay divergence: $75,000 metro vs $90,065 national — Local down, national up — significant split
- Biopharma quit rate: 1.9% — National rate; signals limited voluntary turnover
Key takeaways
Research Scientist pay is pulling away from the national rate.
Metro median advertised pay of $150,000 versus $130,339 nationally points to intensified local competition for R&D talent, likely amplified by San Diego-area organizations drawing from the same Southern California labor pool despite a 34% drop in San Diego biotech VC funding. Expect upward pressure to continue as capital-constrained competitors still bid for the same scientists.
CRA pay is falling locally while rising nationally — a divergence worth investigating.
Metro CRA advertised pay dropped to $75,000 even as the national median climbed to $90,065, a gap that may reflect a shift toward outsourcing clinical operations to CROs instead of retaining in-house staff. Given that experienced CRAs remain the national bottleneck, falling local pay could mean the metro is losing senior clinical talent to remote or outsourced arrangements without solving the shortage.
Regulatory affairs compensation softening locally tracks a national pullback.
Regulatory Affairs Specialist advertised pay fell to $100,808 locally and $103,780 nationally, even as EU and UK regulatory reforms are driving acute demand for compliance talent abroad. Domestic softening alongside overseas tightening suggests U.S. employers may be deprioritizing regulatory headcount growth relative to clinical and R&D functions this cycle.
Lab Technician pay decline signals entry-level margin pressure.
Metro Lab Technician advertised pay dropped significantly to $46,800 against a stable $47,840 national figure, consistent with statewide data showing biotechnology technicians averaging under $54,000 even as life sciences manufacturing wages run roughly double the statewide average. Build-vs-outsource calculus for routine lab and quality functions favors retaining in-house work here, where entry-level labor costs remain comparatively soft.
Median advertised pay by role — Riverside-San Bernardino-Ontario, CA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $115,348 | $150,000 | $165,454 | Significant increase | $130,339 |
| Clinical Research Associate | $64,782 | $75,000 | $82,500 | Moderate decline | $90,065 |
| Lab Technician | $43,770 | $46,800 | $52,000 | Significant decline | $47,840 |
| Regulatory Affairs Specialist | $88,205 | $100,808 | $114,400 | Significant decline | $103,780 |
| Clinical Data Manager * | $108,755 | $139,085 | $154,900 | Stable | $123,653 |
| Biostatistician * | $113,821 | $135,200 | $169,375 | Moderate increase | $131,958 |
| Validation Engineer * | $95,396 | $114,536 | $122,273 | Stable | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Riverside-San Bernardino-Ontario unemployment eased to 5.9% in September from 6.2% in August, with gains concentrated in public-sector education, agriculture, and transportation — sectors with little overlap to the life sciences talent pool. Life sciences employers in this metro continue to draw from a thin regional base of specialized scientific and regulatory talent, competing against better-capitalized San Diego and Bay Area organizations even as statewide biotech venture funding diverges sharply by region.
What it means
Advertised pay for Research Scientist roles in the metro has risen to a $150,000 median — above the $130,339 national figure — signaling local employers are bidding up for a scarce credential pool even as regional unemployment improves. Declines in advertised pay for Clinical Research Associate ($75,000, down against a national median climbing to $90,065) and Regulatory Affairs Specialist ($100,808, down against a declining national figure) suggest employers may be substituting lower-cost hires or shifting work to CROs instead of competing head-on for experienced talent. Organizations should evaluate whether falling local CRA and regulatory affairs advertised pay reflects real cost control or a signal that harder-to-fill senior requisitions are being quietly outsourced.
Looking ahead
Early indicator: Watch whether Research Scientist advertised pay continues climbing past $150,000 as San Diego's VC pullback pushes displaced talent toward Inland Empire and broader Southern California employers. A sustained climb would justify revisiting R&D compensation bands ahead of annual planning.
Emerging pressure point: Falling CRA and regulatory affairs advertised pay locally, against rising or stable national figures, warrants tracking over the next two review cycles to confirm whether this reflects outsourcing to CROs or simply slower local requisition activity.
Worth watching: National biopharma quit rate sits at 1.9%, meaning experienced specialists are largely staying put; any uptick in voluntary departures among Riverside-area clinical or quality staff would be an early signal of competitive poaching beyond normal turnover levels.
Potential inflection point: Statewide core life sciences employment grew in 2025 for the first time in three years; confirm whether that rebound is reaching Inland Empire manufacturing and quality roles or remaining concentrated in San Diego and Bay Area R&D hubs.
Sources
- California Employment Development Department — Riverside-San Bernardino-Ontario unemployment at 5.9% in September, down from 6.2% in August
- California life sciences industry research — San Diego biotech VC funding fell 34% even as statewide funding stabilized
- Life sciences labor market research — Experienced CRAs remain the bottleneck in national biopharma hiring
- Life sciences labor market research — National biopharma quit rate sits at 1.9%
- California life sciences industry research — California core life sciences employment increased in 2025 for first time in three years
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.